AZ's Crestor gets EU nod for broadened Crestor use
AstraZeneca (NYSE: AZN) has won European approval to promote its cholesterol fighter Crestor for preventing heart disease in a large new market of people with healthy cholesterol but other heart risks. Report
Virtual Clinical Trials Summit
Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials
In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.
